Karuna Therapeutics Inc (KRTX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

33 ARCH STREET BOSTON, MA 02110

Karuna Therapeutics, Inc. operates as a biotechnology company. The Company develops therapies for the treatment of chronic mental health disorder. Karuna Therapeutics serves patients in the United States.

Data as of 2020-05-30
Market Cap2.453 Billion Shares Outstanding26.13 Million Avg 30-day Volume236.984 Thousand
P/E Ratio Dividend Yield EPS-0.4
Price/Sales Price cash flow ratio Price free cash flow ratio-70.7
Book Value14.73 Price to Tangible Book6.12 Alpha
Short Interest Ratio % Short Interest to Float R-squared
BETA 52-week High/Low152.0 / 11.24 Stddev
View SEC Filings from KRTX instead.

View recent insider trading info

Funds Holding KRTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding KRTX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

595.7 Thousand total shares from 5 transactions

Exercise Derivative Conversion (M)

42.7 Thousand total shares from 4 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HARRIGAN EDMUND

  • Director
1,946 2020-05-26 3

PURETECH HEALTH LLC

  • 10% Owner
4,739,897 2020-05-22 4

NELSEN ROBERT

  • Director
  • 10% Owner
0 2020-05-21 3

PANDE ATUL

  • Director
24,700 2020-05-15 2

COUGHLIN CHRISTOPHER J

  • Director
39,656 2020-05-14 2

IGNELZI TROY A. CHIEF FINANCIAL OFFICER

0 2020-05-08 4

BRANNAN STEPHEN K. CHIEF MEDICAL OFFICER

10,000 2020-05-01 6

MILLER ANDREW CRAIG CHIEF OPERATING OFFICER

0 2020-05-01 5

JONAS JEFFREY M PRESIDENT & CEO

0 2020-04-28 2

ALEXANDRIA VENTURE INVESTMENTS, LLC

  • 10% Owner
293,013 2020-03-16 2

PRESTON HEATHER

  • Director
5,450 2020-03-10 6

PAUL STEVEN M PRESIDENT & CEO

  • Officer
  • Director
0 2020-02-14 4

ARCH VENTURE PARTNERS IX, LLC

ARCH VENTURE PARTNERS IX, L.P.

ARCH VENTURE PARTNERS IX OVERAGE, L.P.

ARCH VENTURE FUND IX, L.P.

ARCH VENTURE FUND IX OVERAGE, L.P.

CRANDELL KEITH

BYBEE CLINTON

  • 10% Owner
8,243,039 2020-02-10 2

HEALY JAMES

  • Director
  • 10% Owner
0 2020-01-21 4

CHOWRIRA BHARAT M

  • Director
10,000 2019-07-01 2

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

PURETECH HEALTH LLC - > 10% Owner

2020-05-22 S 5,500 $84.50 d 4,739,897 4,739,897.00 direct

PURETECH HEALTH LLC - > 10% Owner

2020-05-22 S 550,000 $81.00 d 4,745,397 4,739,897.00 direct

IGNELZI TROY A. CHIEF FINANCIAL OFFICER

2020-05-08 M 7,500 d 258,794 0.00 direct

IGNELZI TROY A. CHIEF FINANCIAL OFFICER

2020-05-08 S 7,500 $83.38 d 0 0.00 direct yes

IGNELZI TROY A. CHIEF FINANCIAL OFFICER

2020-05-08 M 7,500 $9.20 a 7,500 0.00 direct

BRANNAN STEPHEN K. CHIEF MEDICAL OFFICER

2020-05-01 M 7,728 d 63,829 10,000.00 direct

BRANNAN STEPHEN K. CHIEF MEDICAL OFFICER

2020-05-01 M 7,728 $5.45 a 17,728 10,000.00 direct

MILLER ANDREW CRAIG CHIEF OPERATING OFFICER

2020-05-01 S 25,000 $76.98 d 0 0.00 direct yes

BRANNAN STEPHEN K. CHIEF MEDICAL OFFICER

2020-05-01 M 2,500 d 71,557 10,000.00 direct

BRANNAN STEPHEN K. CHIEF MEDICAL OFFICER

2020-05-01 M 2,500 $5.45 a 10,000 10,000.00 direct

MILLER ANDREW CRAIG CHIEF OPERATING OFFICER

2020-05-01 M 25,000 $7.27 a 25,000 0.00 direct

BRANNAN STEPHEN K. CHIEF MEDICAL OFFICER

2020-05-01 S 7,728 $79.38 d 10,000 10,000.00 direct yes

MILLER ANDREW CRAIG CHIEF OPERATING OFFICER

2020-05-01 M 25,000 d 67,796 0.00 direct

COUGHLIN CHRISTOPHER J

2020-04-24 A 25,000 a 25,000 0.00 direct

Elevate your investments